Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00417846 · ClinicalTrials.gov registry record

Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)

A clinical trial of Choroidal Neovascularization and Maculopathy, Age-Related, sponsored by Johns Hopkins University.

Completed
Registry status
98
Enrollment target
4
Study locations

NCT00417846: Completed study of Choroidal Neovascularization and Maculopathy, Age-Related, sponsored by Johns Hopkins University.

NCT00417846 is a study of Choroidal Neovascularization and Maculopathy, Age-Related that has completed, run by Johns Hopkins University. The registered enrollment target is 98 participants, below the 172-participant average among 7 other Choroidal Neovascularization trials with a reported enrollment target (43% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00417846, a study of Choroidal Neovascularization and Maculopathy, Age-Related, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
98 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to determine the sensitivity of the optical coherence tomography (OCT) test in detecting neovascular AMD in eyes at high risk for CNV development. In order to test this hypothesis, we are conducting a multi-center clinical study at four participating clinical centers. A total of 227 participants will be enrolled. Participants will be followed-up for a period of two years, or until CNV develops in the study eye for which treatment is recommended, to determine the occurrence of CNV. The fundamental design principles of the study are simplicity and parsimony.

Conditions Studied

Choroidal Neovascularization Maculopathy, Age-Related

Study Locations (4)

California

  • Retina Vitreous Associates - Beverly Hills

Maryland

  • The Wilmer Eye Institute at Johns Hopkins - Baltimore

Massachusetts

  • Ophthalmic Consultants of Boston - Boston

Ohio

  • Retina Associates of Cleveland - Beachwood

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2007-01
Est. Completion 2009-08
Johns Hopkins University

1,448 total trials

What the finished NCT00417846 record still lists

NCT00417846 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 172-participant average among 7 other Choroidal Neovascularization trials with a reported enrollment target (43% lower).

The record links to 2 conditions, with Choroidal Neovascularization appearing as the primary indexed condition, and to 0 interventions.

NCT00417846 reports a single indexed study location in California, Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00417846 about?

NCT00417846 is a clinical study titled "Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)". The purpose of this study is to determine the sensitivity of the optical coherence tomography (OCT) test in detecting neovascular AMD in eyes at high risk for CNV development. In order to test this hypothesis, we are conducting a multi-center clinical study at four participating clinical centers. A ...

What is the current status of trial NCT00417846?

This trial is currently completed. The enrollment target is 98 participants. The study started on 2007-01. Estimated completion is 2009-08.

What conditions does trial NCT00417846 study?

This clinical trial studies the following conditions: Choroidal Neovascularization, Maculopathy, Age-Related.

Who is sponsoring clinical trial NCT00417846?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00417846 being conducted?

This trial has 4 study locations across California, Maryland, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Choroidal Neovascularization

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02926729 · 98 participants · NA

    Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy

  • NCT03382977 · 98 participants · Phase 1

    Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

  • NCT04577014 · 98 participants · Phase 1

    Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

  • NCT04817618 · 98 participants · Phase 3

    Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00417846, the US trial registry maintained by the National Library of Medicine. NCT00417846 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.